<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of Pharmacy and Health Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPHR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2321-3647</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPHR508001</article-id>
      <title-group>
        <article-title>A Review On Analytical Methods For Estimation of Formoterol Fumarate In Pharmaceutical Dosage Form and Biological Fluids</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Neval</surname>
            <given-names>Priyanka</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patel</surname>
            <given-names>Dhara</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patel</surname>
            <given-names>Khushboo</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meshram</surname>
            <given-names>Dhananjay</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2017-08-01">
        <month>08</month>
        <day>01</day>
        <year>2017</year>
      </pub-date>
      <volume>5</volume>
      <issue>8</issue>
      <abstract>
        <p>Formoterol fumarate is a selective long acting β2 adrenergic receptor agonist indicated for the treatment of chronic obstructive pulmonary disease (COPD). Various analytical methods used for the estimation of Formoterol fumarate alone and combination with other drugs have been reviewed in this paper. These are  include Ultraviolet spectrometry, High performance thin layer chromatography, High performance liquid chromatography, Ion pair to determine the amount of Formoterol fumarate in bulk drugs and pharmaceutical formulations as well as in Biological Fluids. Stability indicating and impurity profiling methods for Formoterol fumarate are also described. These analytical methods can be used for qualitative and quantitative estimation of Formoterol fumarate and / or its related impurities or degradants in bulk and formulation.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Formoterol fumarate</kwd>
        <kwd>analytical methods</kwd>
        <kwd>estimation</kwd>
        <kwd>formulation and Biological Fluids.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
